Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension,JAMA Internal Medicine

当前位置： X-MOL 学术 › JAMA Intern. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension
JAMA Internal Medicine ( IF 22.5 ) Pub Date : 2020-04-01 , DOI: 10.1001/jamainternmed.2019.7454
George Hripcsak _{1,

2,

3} , Marc A Suchard _{3,

4,

5} , Steven Shea _{1,

3,

6} , RuiJun Chen _{1,

3,

7} , Seng Chan You _{3,

8} , Nicole Pratt _{3,

9} , David Madigan _{3,

10} , Harlan M Krumholz _{3,

11,

12,

13} , Patrick B Ryan _{1,

3,

14} , Martijn J Schuemie _{3,

4,

14}

Affiliation

Department of Biomedical Informatics, Columbia University Medical Center, New York, New York.
Medical Informatics Services, NewYork-Presbyterian Hospital, New York.
Observational Health Data Sciences and Informatics, New York, New York.
Fielding School of Public Health, Department of Biostatistics, University of California, Los Angeles, Los Angeles.
David Geffen School of Medicine, Department of Biomathematics, University of California, Los Angeles, Los Angeles.
Department of Medicine, Columbia University, New York, New York.
Department of Medicine, Weill Cornell Medical College, New York, New York.
Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.
Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia.
Department of Statistics, Columbia University, New York, New York.
Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.
Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut.
Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey.

This cohort study compares cardiovascular and safety outcomes of chlorthalidone and hydrochlorothiazide as first-line therapies for adults with hypertension.

中文翻译：